70 related articles for article (PubMed ID: 11055219)
1. [L-arginine in the lacrimal fluid of patients with diabetic retinopathy and the possible role of nitric oxide in the pathogenesis of retinal ischemia].
Arkhipova MM; Neroev VV; Baratova LA; Lysenko VS
Vestn Oftalmol; 2000; 116(2):23-4. PubMed ID: 11055219
[TBL] [Abstract][Full Text] [Related]
2. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide in retinal cell death.
Roth S
Clin Neurosci; 1997; 4(5):216-23. PubMed ID: 9292247
[TBL] [Abstract][Full Text] [Related]
4. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
[TBL] [Abstract][Full Text] [Related]
6. [Significance of serotonin in the pathogenesis of diabetic retinopathy and central chorioretinal dystrophy].
Mukha AI; Korzenkova LV; Fedorova NV; Syromiatnikova ED
Vestn Oftalmol; 2002; 118(4):31-3. PubMed ID: 12371320
[TBL] [Abstract][Full Text] [Related]
7. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
[TBL] [Abstract][Full Text] [Related]
10. Influence of flickering light on the retinal vessels in diabetic patients.
Mandecka A; Dawczynski J; Blum M; Müller N; Kloos C; Wolf G; Vilser W; Hoyer H; Müller UA
Diabetes Care; 2007 Dec; 30(12):3048-52. PubMed ID: 17728481
[TBL] [Abstract][Full Text] [Related]
11. Altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor.
Kawano K; Masuda H; Yano M; Kihara K; Sugimoto A; Azuma H
J Urol; 2006 Jul; 176(1):387-93. PubMed ID: 16753448
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effects of prostacyclin and nitric oxide in patients with type I diabetes and ischemic or edematous retinopathy.
De La Cruz JP; Moreno A; Guerrero A; de La Cuesta FS
Platelets; 2001 Jun; 12(4):210-7. PubMed ID: 11454255
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of diabetic retinopathy in type 2 diabetic patients.
Cai XL; Wang F; Ji LN
Chin Med J (Engl); 2006 May; 119(10):822-6. PubMed ID: 16732984
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies to types II and IV collagens, tumor necrosis factor-alpha and circulating immune complexes in lacrimal fluid and serum of patients with diabetic retinopathy and different stages].
Balashova LM; Zaĭtseva NS; Teplinskaia LE; Koval'chuk LV; Gankovskaia LV; Obraztsova EN; Aronskind MS
Vestn Oftalmol; 2000; 116(3):31-4. PubMed ID: 10918849
[TBL] [Abstract][Full Text] [Related]
16. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
[TBL] [Abstract][Full Text] [Related]
17. Amino acids, arginase and nitric oxide in vascular health.
Huynh NN; Chin-Dusting J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):1-8. PubMed ID: 16445692
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide in flow-through venous flaps and effects of L-arginine and nitro-L-arginine methyl ester (L-NAME) on nitric oxide and flap survival in rabbits.
Ozyazgan I; Ozköse M; Başkol G
Ann Plast Surg; 2007 Nov; 59(5):550-7. PubMed ID: 17992151
[TBL] [Abstract][Full Text] [Related]
19. Expression of inducible nitric oxide synthase and effects of L-arginine on colonic nitric oxide production and fluid transport in patients with "minimal colitis".
Perner A; Andresen L; Normark M; Fischer-Hansen B; Rask-Madsen J
Scand J Gastroenterol; 2005 Sep; 40(9):1042-8. PubMed ID: 16165717
[TBL] [Abstract][Full Text] [Related]
20. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
